Becker's Clinical Quality & Infection Control

Becker's Infection Control and Clinical Quality September 2015

Issue link: https://beckershealthcare.uberflip.com/i/571945

Contents of this Issue

Navigation

Page 23 of 47

HIBICLENS ® , focused on patient Hibiclens ® , the Hibiclens ® logo and Mölnlycke ® are registered trademarks of Mölnlycke ® Heath Care AB. Distributed by Mölnlycke ® Health Care US, LLC, Norcross, Georgia 30092. © 2015 Mölnlycke ® Health Care AB. All rights reserved. MHC-2015-3429 The fight against infection starts at home HIBICLENS ® is a skin cleanser as well as an antiseptic that kills a broad spectrum of pathogens. 1 Its active ingredient, chlorhexidine gluconate (CHG), kills germs on contact 2 and bonds with the skin to keep killing pathogens for up to 24 hours. 3 The CDC and AORN recommend patients shower with an antiseptic skin cleanser prior to surgery to reduce the risk of infection. Multiple studies have shown 4% CHG can help significantly reduce surgical site infections when used as part of a bundled approach. 4,5,6 References: 1. Denton, G. Chlorhexidine. In: Block S, ed. Disinfection, Sterilization, and Preser vation, 4th ed. Philadelphia: Lea & Febiger, 1991:274–89.3. 2. Paulson, Dar yl S. Persistent and Residual Antimicrobial Effects: Are They Impor tant in the Clinical Setting? Infection Control Today 2005; Vol 9, No 4. 3. MBT Study No. 582-106, Protocol #582.1.11.12.12. 4. Schweizer M, Chiang H, Septimus E, et al. Association of a Bundled Intervention With Surgical Site Infections Among Patients Undergoing Cardiac, Hip, or Knee Surgery JAMA. 2015; 313(21): 2162-2171. 5. Rao, Nalini., et al. "A Preoperative Decolonization Protocol for Staphylococcus Aureus Prevents Or thopaedic Infections." Clinical Or thopaedics and Related Research 466.6 (2008): 1343-348. 6. Cima, Rober t, et al. "Colorectal Surger y Surgical Site Infection Reduction Program." American College of Surgeons (2013): 23-33. 7. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Critical Care Medicine 2009 Jun; 37(6): 1858-1865. 8. Rupp ME, Cavalieri RJ, Lyden E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infection Control and Hospital Epidemiology 2012 Nov; 33(11): 1094-1000.

Articles in this issue

view archives of Becker's Clinical Quality & Infection Control - Becker's Infection Control and Clinical Quality September 2015